Genus Company Profile

« Back to Dashboard

What is the competitive landscape for GENUS

GENUS has twenty-nine approved drugs.

There are ten US patents protecting GENUS drugs.

Summary for Genus

US Patents:	10
Tradenames:	23
Ingredients:	22
NDAs:	29

Drugs and US Patents for Genus

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-006	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No	10,231,931		Y
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-006	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No	10,406,108		Y
Genus Lifesciences	POTASSIUM CHLORIDE	potassium chloride	SOLUTION;ORAL	206814-002	Dec 22, 2014	AA	RX	Yes	Yes	12,539,314		Y
Genus Lifesciences	POTASSIUM CHLORIDE	potassium chloride	SOLUTION;ORAL	206814-002	Dec 22, 2014	AA	RX	Yes	Yes	12,728,138		Y
Genus	MEPERIDINE HYDROCHLORIDE	meperidine hydrochloride	TABLET;ORAL	040893-002	Jun 24, 2009		DISCN	No	No
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-009	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No	10,406,108		Y

Expired US Patents for Genus

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-001	Sep 14, 2016	9,364,439
Genus	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006	6,730,288
Genus	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006	9,492,384
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-002	Sep 14, 2016	8,206,741
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-001	Sep 14, 2016	8,206,741
Genus	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006	8,962,000

Paragraph IV (Patent) Challenges for GENUS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-release Tablets	81 mg/40 mg		2016-10-14

International Patents for Genus Drugs

Country	Patent Number	Estimated Expiration
South Korea	101743847
Japan	6239709
Eurasian Patent Organization	201491285
South Korea	20150030782
Japan	6027890
South Africa	200702702

Supplementary Protection Certificates for Genus Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2435024	2190014-7	Sweden		PRODUCT NAME: A COMBINATION OF FORMOTEROL INCLUDING ANY PHARMACEUUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, GLYCOPYRROLATE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, AND BUDESONIDE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALT, ESTERS ORSOLVATES THEREOF; REG. NO/DATE: EU/1/20/1498 20201210
1441735	2008/010	Ireland		PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
0613371	SPC/GB02/033	United Kingdom		PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
0809498	SPC/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
1499331	13C0055	France		PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
0809498	10C0038	France		PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Genus
• Genus Lifesciences